MXLMAXLINEAR, INC

Nasdaq maxlinear.com


$ 14.55 $ 0.21 (1.46 %)    

Monday, 16-Sep-2024 15:59:59 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 14.55
$ 14.02
$ 14.53 x 100
-- x --
$ 14.02 - $ 14.79
$ 11.08 - $ 26.59
925,365
na
1.22B
$ 1.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-24-2024 06-30-2024 10-Q
2 04-24-2024 03-31-2024 10-Q
3 01-31-2024 12-31-2023 10-K
4 10-25-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-26-2023 03-31-2023 10-Q
7 02-01-2023 12-31-2022 10-K
8 10-25-2022 09-30-2022 10-Q
9 07-27-2022 06-30-2022 10-Q
10 04-27-2022 03-31-2022 10-Q
11 02-02-2022 12-31-2021 10-K
12 10-27-2021 09-30-2021 10-Q
13 07-28-2021 06-30-2021 10-Q
14 04-28-2021 03-31-2021 10-Q
15 02-11-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 07-23-2020 06-30-2020 10-Q
18 04-29-2020 03-31-2020 10-Q
19 02-05-2020 12-31-2019 10-K
20 10-25-2019 09-30-2019 10-Q
21 07-25-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-05-2019 12-31-2018 10-K
24 10-30-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 02-20-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 02-09-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-09-2016 03-31-2016 10-Q
35 02-17-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-06-2015 03-31-2015 10-Q
39 02-23-2015 12-31-2014 10-K
40 10-30-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 northland-capital-markets-maintains-outperform-on-maxlinear-lowers-price-target-to-25

Northland Capital Markets analyst Tim Savageaux maintains MaxLinear (NASDAQ:MXL) with a Outperform and lowers the price targ...

 craig-hallum-maintains-hold-on-maxlinear-lowers-price-target-to-28

Craig-Hallum analyst Richard Shannon maintains MaxLinear (NASDAQ:MXL) with a Hold and lowers the price target from $38 to $28.

Core News & Articles
Market-Moving News for July 25th
07/25/2024 13:01:55

EW: -24% | Edwards Lifesciences shares are trading lower after the company reported worse-than-expected Q2 sales results and is...

 susquehanna-maintains-positive-on-maxlinear-lowers-price-target-to-26

Susquehanna analyst Christopher Rolland maintains MaxLinear (NASDAQ:MXL) with a Positive and lowers the price target from $3...

 benchmark-maintains-buy-on-maxlinear-lowers-price-target-to-22

Benchmark analyst David Williams maintains MaxLinear (NASDAQ:MXL) with a Buy and lowers the price target from $28 to $22.

 needham-downgrades-maxlinear-to-hold

Needham analyst Quinn Bolton downgrades MaxLinear (NASDAQ:MXL) from Buy to Hold.

 maxlinear-q2-2024-adj-eps-025-misses-019-estimate-sales-91990m-miss-100044m-estimate

MaxLinear (NASDAQ:MXL) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.19) by...

 stifel-maintains-buy-on-maxlinear-raises-price-target-to-30

Stifel analyst Tore Svanberg maintains MaxLinear (NASDAQ:MXL) with a Buy and raises the price target from $26 to $30.

 susquehanna-maintains-positive-on-maxlinear-raises-price-target-to-30

Susquehanna analyst Christopher Rolland maintains MaxLinear (NASDAQ:MXL) with a Positive and raises the price target from $2...

 benchmark-reiterates-buy-on-maxlinear-maintains-28-price-target

Benchmark analyst David Williams reiterates MaxLinear (NASDAQ:MXL) with a Buy and maintains $28 price target.

 benchmark-reiterates-buy-on-maxlinear-maintains-28-price-target

Benchmark analyst David Williams reiterates MaxLinear (NASDAQ:MXL) with a Buy and maintains $28 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION